Gyre Therapeutics Inc (GYRE) returns
Gyre Therapeutics returns over 10 years
$1,000 invested in Gyre Therapeutics ten years ago was worth $204.77 at the close on October 30, 2026, with dividends reinvested: an average return of -14.7% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -37.9% | — | $621.42 | -0.9% |
| 3 months | -21.6% | — | $783.99 | +2.1% |
| Year to date | -35.5% | — | $645.18 | +11.7% |
| 1 year | -40.5% | — | $595.43 | +12.4% |
| 3 years | -40.6% | -15.9% | $593.91 | +88.5% |
| 5 years | -31.8% | -7.4% | $681.51 | +76.0% |
| 10 years | -79.5% | -14.7% | $204.77 | +316.6% |
Gyre Therapeutics return by calendar year
| Year | GYRE | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -35.5% | +11.7% | -47.2% |
| 2025 | -41.7% | +17.7% | -59.4% |
| 2024 | -52.9% | +24.9% | -77.8% |
| 2023 | +521.5% | +26.2% | +495.3% |
| 2022 | +122.6% | -18.2% | +140.8% |
| 2021 | -85.5% | +28.7% | -114.3% |
| 2020 | -7.3% | +18.4% | -25.7% |
| 2019 | -13.7% | +31.2% | -44.9% |
| 2018 | -42.2% | -4.6% | -37.6% |
| 2017 | +39.9% | +21.7% | +18.2% |
| 2016 | -79.2% | +12.0% | -91.2% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: GYRE financials
No forecast, no recommendation. This page describes Gyre Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.